(VIANEWS) – Civista Bancshares (CIVB), First Financial Bancorp. (FFBC), Allegion plc Ordinary Shares (ALLE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Civista Bancshares (CIVB)
45% sales growth and 11.43% return on equity
Civista Bancshares, Inc. operates as the financial holding company for Civista Bank that provides community banking services. The company collects a range of customer deposits; and offers commercial, commercial and residential real estate mortgage, real estate construction, and consumer loans, as well as letters of credit. It also purchases securities; and provides trust and third party insurance services. The company operates branch banking offices in Ohio communities, including Sandusky, Norwalk, Berlin Heights, Huron, Port Clinton, Castalia, New Washington, Shelby, Willard, Greenwich, Plymouth, Shiloh, Akron, Dublin, Plain City, Urbana, Russells Point, West Liberty, Quincy, Dayton, and Beachwood; and Indiana communities comprising Lawrenceburg, Aurora, West Harrison, Milan, Osgood, and Versailles. It also operates loan production offices in Westlake, Ohio; and Fort Mitchell, Kentucky. The company was formerly known as First Citizens Banc Corp and changed its name to Civista Bancshares, Inc. in May 2015. Civista Bancshares, Inc. was founded in 1884 and is headquartered in Sandusky, Ohio.
Earnings Per Share
As for profitability, Civista Bancshares has a trailing twelve months EPS of $2.6.
PE Ratio
Civista Bancshares has a trailing twelve months price to earnings ratio of 7.18. Meaning, the purchaser of the share is investing $7.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.43%.
2. First Financial Bancorp. (FFBC)
22.3% sales growth and 10.12% return on equity
First Financial Bancorp. operates as the bank holding company for First Financial Bank that provides commercial banking and related services to individuals and businesses in Ohio, Indiana, Kentucky, and Illinois. The company accepts various deposit products, such as interest-bearing and noninterest-bearing accounts, time deposits, and cash management services for commercial customers. It also provides real estate loans secured by residential property, such as one to four family residential housing units or commercial property comprising owner-occupied and/or investor income producing real estate consisting of apartments, shopping centers, or office buildings; commercial and industrial loans for various purposes, including inventory, receivables, and equipment; consumer loans comprising new and used vehicle loans, second mortgages on residential real estate, and unsecured loans; and home equity lines of credit. In addition, the company offers commercial financing to the insurance industry, registered investment advisors, certified public accountants, indirect auto finance companies, and restaurant franchisees. Further, it provides a range of trust and wealth management services; and lease and equipment financing services. As of December 31, 2021, the company operated 139 full service banking centers, 29 of which are leased facilities. It operates 62 banking centers in Ohio, three banking centers in Illinois, 62 banking centers in Indiana, and 12 banking centers in Kentucky. First Financial Bancorp. was founded in 1863 and is headquartered in Cincinnati, Ohio.
Earnings Per Share
As for profitability, First Financial Bancorp. has a trailing twelve months EPS of $2.34.
PE Ratio
First Financial Bancorp. has a trailing twelve months price to earnings ratio of 9.3. Meaning, the purchaser of the share is investing $9.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.12%.
3. Allegion plc Ordinary Shares (ALLE)
18.7% sales growth and 53.7% return on equity
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers and controls; doors and door systems; electronic security products; electronic, biometric and mobile access control systems; exit devices; locks, locksets, portable locks, and key systems; time, attendance, and workforce productivity systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facilities, including education, healthcare, government, hospitality, commercial office, and single and multi-family residential markets under the CISA, Interflex, LCN, Schlage, SimonsVoss, and Von Duprin brands. It sells its products and solutions through distribution and retail channels, such as specialty distribution, e-commerce, and wholesalers, as well as through various retail channels comprising do-it-yourself home improvement centers, on-line and e-commerce platforms, and small specialty showroom outlets. Allegion plc was incorporated in 2013 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, Allegion plc Ordinary Shares has a trailing twelve months EPS of $5.1.
PE Ratio
Allegion plc Ordinary Shares has a trailing twelve months price to earnings ratio of 19.73. Meaning, the purchaser of the share is investing $19.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.7%.
4. Public Storage (PSA)
11.9% sales growth and 47.74% return on equity
Public Storage, a member of the S&P 500 and FT Global 500, is a REIT that primarily acquires, develops, owns and operates self-storage facilities. At September 30, 2020, we had: (i) interests in 2,504 self-storage facilities located in 38 states with approximately 171 million net rentable square feet in the United States, (ii) an approximate 35% common equity interest in Shurgard Self Storage SA (Euronext Brussels:SHUR) which owned 239 self-storage facilities located in seven Western European nations with approximately 13 million net rentable square feet operated under the “Shurgard” brand and (iii) an approximate 42% common equity interest in PS Business Parks, Inc. (NYSE:PSB) which owned and operated approximately 28 million rentable square feet of commercial space at September 30, 2020. Our headquarters are located in Glendale, California.
Earnings Per Share
As for profitability, Public Storage has a trailing twelve months EPS of $23.51.
PE Ratio
Public Storage has a trailing twelve months price to earnings ratio of 13.16. Meaning, the purchaser of the share is investing $13.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.74%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.8%, now sitting on 4.09B for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 13, 2023, the estimated forward annual dividend rate is 12 and the estimated forward annual dividend yield is 3.97%.
Yearly Top and Bottom Value
Public Storage’s stock is valued at $309.36 at 20:22 EST, way below its 52-week high of $421.76 and way higher than its 52-week low of $270.13.
Sales Growth
Public Storage’s sales growth is 17% for the current quarter and 11.9% for the next.
Previous days news about Public Storage(PSA)
- According to Zacks on Tuesday, 4 April, "Life Storage earlier rejected a bid from the industry behemoth Public Storage (PSA Quick QuotePSA – Free Report) ."
5. Humana (HUM)
11.1% sales growth and 17.81% return on equity
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Earnings Per Share
As for profitability, Humana has a trailing twelve months EPS of $22.09.
PE Ratio
Humana has a trailing twelve months price to earnings ratio of 18.48. Meaning, the purchaser of the share is investing $18.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.81%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.6%, now sitting on 92.87B for the twelve trailing months.
Yearly Top and Bottom Value
Humana’s stock is valued at $520.29 at 20:22 EST, under its 52-week high of $571.30 and way higher than its 52-week low of $410.87.
Previous days news about Humana(HUM)
- Humana (hum) upgraded to buy: here's what you should know. According to Zacks on Thursday, 6 April, "The upgrade of Humana to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.", "Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Humana imply an improvement in the company’s underlying business. "
- According to Zacks on Thursday, 6 April, "Investors may want to consider Humana stock for its top and bottom-line expansion along with its steady dividend growth. ", "Better still, Humana recently increased its dividend by 12.4% in February and has now raised it six times in the last five years."
6. Federal Signal Corporation (FSS)
10.4% sales growth and 13.21% return on equity
Federal Signal Corporation, together with its subsidiaries, designs, manufactures, and supplies a suite of products and integrated solutions for municipal, governmental, industrial, and commercial customers in the United States, Canada, Europe, and internationally. It operates through Environmental Solutions Group, and Safety and Security Systems Group. The Environmental Solutions Group segment offers a range of street sweepers, safe-digging trucks ,sewer cleaners, industrial vacuum loaders, vacuum, and hydro-excavation trucks; road-marking, line-removal and waterblasting equipment, dump truck bodies, trailers, and metal extraction support equipment under the Elgin, Vactor, Guzzler, TRUVAC, Westech, Jetstream, Mark Rite Lines, Ox Bodies, Crysteel, J-Craft, Duraclass, Rugby, Travis, OSW, NTE, WTB, Ground Force, Bucks, and Switch-N-Go brand names. It also offers refuse and recycling collection vehicles, camera systems, ice resurfacing equipment, and snow-removal equipment, as well as safety, and security systems. In addition, this segment engages in the sale of parts, service and repair, equipment rental, and training activities. The Safety and Security Systems Group segment provides systems and products for community alerting, emergency vehicles, first responder interoperable communications, and industrial communications. Its products include vehicle lightbars and sirens, industrial signaling equipment, public warning systems, general alarm systems, and public address systems. This segment sells its products under the Federal Signal, Federal Signal VAMA, and Victor brand names. The company sells its products through wholesaler, distributor, independent manufacturer representative, original equipment manufacturer, and direct sales force, as well as independent foreign distributor. Federal Signal Corporation was founded in 1901 and is headquartered in Oak Brook, Illinois.
Earnings Per Share
As for profitability, Federal Signal Corporation has a trailing twelve months EPS of $1.56.
PE Ratio
Federal Signal Corporation has a trailing twelve months price to earnings ratio of 33.66. Meaning, the purchaser of the share is investing $33.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.21%.
Yearly Top and Bottom Value
Federal Signal Corporation’s stock is valued at $52.58 at 20:22 EST, under its 52-week high of $58.15 and way higher than its 52-week low of $31.86.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.1%, now sitting on 1.34B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 16, 2022, the estimated forward annual dividend rate is 0.36 and the estimated forward annual dividend yield is 0.68%.
7. Amphastar Pharmaceuticals (AMPH)
9.3% sales growth and 18.76% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $1.72.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 21.8. Meaning, the purchaser of the share is investing $21.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.76%.
Yearly Top and Bottom Value
Amphastar Pharmaceuticals’s stock is valued at $37.50 at 20:22 EST, way below its 52-week high of $44.46 and way higher than its 52-week low of $26.76.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 498.99M for the twelve trailing months.
Sales Growth
Amphastar Pharmaceuticals’s sales growth is 10.8% for the current quarter and 9.3% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Amphastar Pharmaceuticals’s EBITDA is 25.87.
8. CRA International (CRAI)
5.4% sales growth and 20.92% return on equity
CRA International, Inc., a consulting company, provides economic, financial, and management consulting services in the United States, the United Kingdom, and internationally. It advises clients on economic and financial matters pertaining to litigation and regulatory proceedings; and guides corporations through business strategy and performance-related issues. The company also offers consulting services, including research and analysis, expert testimony, and support in litigation and regulatory proceedings in the areas of finance, accounting, economics, insurance, and forensic accounting and investigations to corporate clients and attorneys. In addition, it offers management consulting services comprising strategy development, performance improvement, corporate strategy and portfolio analysis, estimation of market demand, new product pricing strategies, valuation of intellectual property and other assets, assessment of competitors' actions, and analysis of new sources of supply. The company serves various industries, including agriculture, banking and capital markets, chemicals, communications and media, consumer products, energy, entertainment, financial services, health care, insurance, life sciences, manufacturing, oil and gas, real estate, retail, sports, telecommunications, transportation, and technology, as well as metals, mining, and materials. The company was incorporated in 1965 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, CRA International has a trailing twelve months EPS of $5.98.
PE Ratio
CRA International has a trailing twelve months price to earnings ratio of 18.03. Meaning, the purchaser of the share is investing $18.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.92%.
Moving Average
CRA International’s value is under its 50-day moving average of $116.74 and above its 200-day moving average of $105.26.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 12, 2023, the estimated forward annual dividend rate is 1.44 and the estimated forward annual dividend yield is 1.35%.
